Live Breaking News & Updates on Agenus Inc Stock Exchange

Stay updated with breaking news from Agenus inc stock exchange. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Agenus Presents Positive Efficacy and Safety Outcomes for AGEN2373 at ASCO

AGEN2373 is the first CD137 agonist antibody reporting single agent responses with no major toxicity

Responses reported in patients with prostate cancer, ampullary carcinoma and metastatic vulvar. | June 5, 2023 ....

United States , Mary Crowley Research , American Society Of Clinical Oncology , American Society , Clinical Oncology , Steveno Day , Chief Medical Officer , Antibody Designed , Avoid Hepatoxicity , Advanced Solid Tumors , Minal Barve , Executive Director , Agenus Inc Stock Exchange , Press Release , Etastatic Agen Us00847g7051 ,

Agenus Announces Virtual Annual Shareholders Meeting

Agenus , a leading immuno-oncology company with a pipeline of immunological agents targeting cancer and infectious disease, today announced that its Annual Shareholders Meeting will begin at 10:30. | June 5, 2023 ....

Annual Shareholders Meeting , Agenus Inc Stock Exchange , Press Release , T Agen Us00847g7051 ,

Agenus Provides Corporate Update and First Quarter 2023 Financial Results

At a late-breaking presentation at ASCO-GI, botensilimab/balstilimab combination demonstrated a 63% 12-month overall survival rate in metastatic colorectal cancer patients who have failed a median. | May 9, 2023 ....

United States , New York , Comunidad Autonoma De Cataluna , Garo Armen , Agenus Inc , Society Of Gynecologic Oncology , American Society Of Clinical Oncology , World Congress On Gastrointestinal Cancer , Exchange Commission , Chief Executive Officer , American Society , Clinical Oncology , Gastrointestinal Cancers Symposium , Gynecologic Oncology , Fast Track Designation , Gastrointestinal Cancer , Combination With , First Line Treatment , Patients With , Metastatic Squamous Cell Carcinoma , Combination Therapy , With Advanced Solid Tumors , Risk Factors , Quarterly Report , Annual Report , Agenus Inc Stock Exchange ,

Agenus : Transcript | MarketScreener

Leadership in revolutionizing cancer immunotherapy, Garo Armen, Ph.D., Chairman & CEO, Agenus

Biotech 2050 Podcast

[00:00:00] Rahul. | May 3, 2023 ....

District Of Columbia , United States , Garrow Armen , Rahul Chaturvedi , Raho Chuba , Botten Zumab , Joshua Lederberg , Garo Armen , Rockefeller University , Wall Street , Nobel Laureate , Regulatoryt Cells , Air Force , Agenus Inc Stock Exchange , Press Release , 050 Agen Us00847g7051 ,

Agenus Selected for Late-Breaking Oral Presentation at ESMO-GI

Agenus , a leading immuno-oncology company dedicated to developing innovative treatments for cancer and infectious diseases, today announced a data update on botensilimab in combination with. | May 3, 2023 ....

Comunidad Autonoma De Cataluna , Andreaj Bullock , Beth Israel Deaconess Medical Center , Division Of Medical Oncology , World Congress On Gastrointestinal Cancer , Gastrointestinal Cancer , Assistant Professor , Medical Oncology , Agenus Inc Stock Exchange , Press Release , Ombination Agen Us00847g7051 ,